Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,594 total articles

Wolfe Identifies Business and Information Services Picks Set to Benefit from 2026 Market Tailwinds

Wolfe Identifies Business and Information Services Picks Set to Benefit from 2026 Market Tailwinds

Wolfe’s recent sector review singles out several business and information services companies it expects to outperform in 2026. The firm points to a constructive debt issuance backdrop and stronger equity markets as the primary market forces supporting upside for Moody’s, S&P Global, Fair Isaac Corporation and TransUnion. Each company offers distinc…

Benchmark Starts Coverage of CAVA With Buy Rating, $80 Price Target

Benchmark Starts Coverage of CAVA With Buy Rating, $80 Price Target

Benchmark launched coverage of CAVA Group with a Buy rating and an $80 price target, highlighting the chain's leadership in Mediterranean fast-casual, robust unit-level economics and an expansion trajectory that could lift domestic locations to at least 1,000 by 2032. The firm pointed to high average unit volumes, healthy restaurant-level margins a…

Senators Seek Answers From DOT Over FAA Chief’s Republic Airways Holdings

Senators Seek Answers From DOT Over FAA Chief’s Republic Airways Holdings

Three Democratic senators have formally asked the U.S. Department of Transportation to clarify whether Federal Aviation Administration Administrator Bryan Bedford has sold his Republic Airways shares and whether he will forfeit any gains for failing to divest by an agreed deadline. The request follows Bedford’s December acknowledgment that he had n…

Athens Market Falls as Banks, Telecoms and Household Names Weigh on Index

Athens Market Falls as Banks, Telecoms and Household Names Weigh on Index

Greece's main equity index ended the session lower, with the Athens General Composite slipping 1.69% at the close. Losses were concentrated in the Banking, Telecoms and Household sectors. Decliners outnumbered advancers by a wide margin, while a handful of companies posted notable gains, including two reaching multi-year and all-time peaks.

JPMorgan Lowers Corteva to Neutral, Cites Valuation Constraints

JPMorgan Lowers Corteva to Neutral, Cites Valuation Constraints

JPMorgan has downgraded Corteva from Overweight to Neutral, arguing the stock's current price already reflects much of the upside and that valuation levers are limited until agricultural risks and the planned separation of the seed and crop protection businesses become clearer. The bank adjusted its price target slightly higher after lifting consol…

Rio Tinto Ends Talks with Glencore, Third Attempt to Merge Falls Apart

Rio Tinto Ends Talks with Glencore, Third Attempt to Merge Falls Apart

Rio Tinto confirmed on Feb 5 that discussions with Glencore over a potential takeover have been discontinued after the parties were unable to reach an agreement that would provide value to Rio shareholders. This marks the third time efforts to combine the two firms have been abandoned, underscoring persistent obstacles to large-scale consolidation …

Multiple Bidders Keep Pressure on Lukoil Asset Sale as Carlyle Moves Forward

Multiple Bidders Keep Pressure on Lukoil Asset Sale as Carlyle Moves Forward

Despite a preliminary agreement for U.S. private equity firm Carlyle to acquire Lukoil’s global assets, at least two other bidder groups - including a Chevron-Quantum partnership and an Xtellus-led consortium - continue discussions with Lukoil and U.S. officials. The sale faces regulatory and political checkpoints, with the U.S. Treasury setting a …

Can-Fite Shares Rally After Compassionate-Use Patient Stabilized and Transplanted Following Namodenoson Treatment

Can-Fite Shares Rally After Compassionate-Use Patient Stabilized and Transplanted Following Namodenoson Treatment

Can-Fite BioPharma's stock climbed 9.5% after the company reported that a patient with advanced decompensated liver cirrhosis treated with Namodenoson under compassionate use achieved sufficient clinical stabilization to proceed to a successful liver transplant once a donor became available. The company highlighted the case while Namodenoson contin…